Hit enter to search or ESC to close

Recent Grants Related to Ebola Virus Disease

admin

To help academic community quickly catch up on the most recent research grants awarded by US government, Paper Digest Team extracted all grants related to Ebola Virus Disease on our radar (including old grants related to this topic). These results are sorted by relevance & date and will be updated on a weekly basis.

If you do not want to miss interesting academic papers, you are welcome to sign up our free service to get a one sentence summary of each new paper published in your area on a daily basis. You will also have access to our console that allows you to search for papers, patents, and grants. You are welcome to follow us on Twitter and Linkedin to get updated with new conference digests.

Paper Digest Team
New York City, New York, 10017
team@paperdigest.org

TABLE 1: Recent Grants Related to Ebola Virus Disease

Project PI(s) Organization Start
1 MPOPHC: Integrating human risk perception and social processes into policy responses in an epidemiological model SUZANNE LENHART; BRIAN BECKAGE; CHARLES SIMS; KATHERINE LACASSE; UNIVERSITY OF VERMONT & STATE AGRICULTURAL COLLEGE 2024-10-01
2 Emerging and Re-Emerging Pathogens Research Training Program in DRC (EREP-RTP-DRC) JEAN-JACQUES TAMFUM MUYEMBE-TAMFUM INSTITUT NATIONAL / RECHERCHE BIOMEDICAL 2024-06-18
3 Research Project 2: Role of Posttranscriptional Regulatory Networks in the Pathogenesis of Ebola Virus Disease ALEXANDER BUKREYEV UNIVERSITY OF TEXAS MED BR GALVESTON 2024-06-05
4 Research Project 3: Role of Posttranslational Protein Modifications in the Pathogenesis of Ebola Virus Disease ALEXANDER BUKREYEV UNIVERSITY OF TEXAS MED BR GALVESTON 2024-06-05
5 Molecular Mechanisms of the Dysregulated Immune Response to Ebola Virus ALEXANDER BUKREYEV UNIVERSITY OF TEXAS MED BR GALVESTON 2024-06-05
6 Research Project 1: Role of Epigenetic and Transcriptional Mechanisms in the Pathogenesis of Ebola Virus Disease ALEXANDER BUKREYEV UNIVERSITY OF TEXAS MED BR GALVESTON 2024-06-05
7 West African Center for Emerging Infectious Diseases SCOTT C WEAVER UNIVERSITY OF TEXAS MED BR GALVESTON 2024-06-03
8 Spillover of Ebola and other filoviruses at ecological boundaries PATRICK STEPHENS OKLAHOMA STATE UNIVERSITY STILLWATER 2024-05-21
9 Development of Optofluidic Resonators for Filoviral Detection ABRAHAM JALEEL QAVI UNIVERSITY OF CALIFORNIA-IRVINE 2024-05-17
10 “Contributions of Ebola and Marburg virus VP30 and VP24 proteins to viral RNA synthesis, assembly and egress” CHRISTOPHER F BASLER WASHINGTON UNIVERSITY 2024-05-16
11 Antibody and Reagent Development Core DAISY W LEUNG WASHINGTON UNIVERSITY 2024-05-16
12 Real-time tracking of virus evolution for vaccine strain selection and epidemiological investigation TREVOR BC BEDFORD FRED HUTCHINSON CANCER CENTER 2024-05-09
13 The Protective and Pathologic Features of the EVD Survivor Immune System WILLIAM FISCHER UNIV OF NORTH CAROLINA CHAPEL HILL 2024-04-23
14 Cryo-EM of Helical Protein and Nucleoprotein Polymers at Near Atomic Resolution EDWARD H. EGELMAN UNIVERSITY OF VIRGINIA 2024-04-19
15 Cryo-EM of Helical Protein and Nucleoprotein Polymers at Near Atomic Resolution EDWARD H. EGELMAN UNIVERSITY OF VIRGINIA 2024-04-18
16 Tolerance and resistance responses of African bats to viral antigens: Immunological tradeoffs in zoonotic reservoir hosts. DEEANN REEDER BUCKNELL UNIVERSITY 2024-03-07
17 Mali-Guinea Emerging Infectious Disease Research Training Program (Mali-Guinea EID-RTP) SEYDOU DOUMBIA UNIV OF SCIENCES, TECH & TECH OF BAMAKO 2024-02-21
18 Improving survival from Burkholderia pseudomallei and other pathogenic intracellular bacteria GEORGE NORBERT COX BOLDER BIOTECHNOLOGY, INC. 2024-01-23
19 Center for Viral Systems Biology (CViSB) KRISTIAN GRAUGAARD ANDERSEN SCRIPPS RESEARCH INSTITUTE, THE 2024-01-12
20 Project 1 ROBERT F GARRY SCRIPPS RESEARCH INSTITUTE, THE 2024-01-12
21 Project 2 KRISTIAN GRAUGAARD ANDERSEN SCRIPPS RESEARCH INSTITUTE, THE 2024-01-12
22 Defining how ubiquitination of Ebola viral proteins affect host-viral dynamics GRACE UWASE WASHINGTON UNIVERSITY 2023-12-20
23 Merging machine learning and mechanistic models to improve prediction and inference in emerging epidemics JUSTIN LESSLER UNIV OF NORTH CAROLINA CHAPEL HILL 2023-12-20
24 Insight into the Ebola virus glycoprotein fusion mechanism gleaned from the 2013-2016 epidemic GP-A82V variant JEREMY LUBAN UNIV OF MASSACHUSETTS MED SCH WORCESTER 2023-12-13
25 Determining Tropism and Mechanisms of Ebola Virus Entry in Placental Tissues HANORA ANNE MARIE VAN ERT UNIVERSITY OF IOWA 2023-10-26
26 Functional genomic characterization of diverse bat innate immune mechanisms ANNA BRUCHEZ CASE WESTERN RESERVE UNIVERSITY 2023-10-24
27 Preclinical development of a Nipah Virus inhibitor SEAN EKINS COLLABORATIONS PHARMACEUTICALS, INC. 2023-09-15
28 “PA21259, SBIR, Phase I, Aptamer-upconverting nanocrystal conjugate lateral flow assay for immediate Ebola virus detection” SOMA BANERJEE APTALOGIC, INC 2023-08-23
29 A Fully Integrated Point-of-Care Test for Ebola ASHUTOSH CHILKOTI DUKE UNIVERSITY 2023-08-21
30 A modular platform for infectious disease surveillance at point-of-need. JAY KENNETH FISHER REDBUD LABS, INC. 2023-08-16
31 Defining the effect of Plasmodium infection on Ebola virus vaccine efficacy WENDY JEAN MAURY UNIVERSITY OF IOWA 2023-08-11
32 Monoclonal Antibody Cocktail for Treatment of Marburg Virus Disease M JAVAD AMAN ABVACC, INC. 2023-08-11
33 Learning from the Ebola success: Can a mAb also save lives after yellow fever infection? DAVID I WATKINS MABLOC, LLC 2023-08-10
34 Elucidating mechanisms of interferon gamma that protect against Ebola virus infection WENDY JEAN MAURY UNIVERSITY OF IOWA 2023-08-10
35 High throughput screening and drug discovery for antagonists of the Ebola VP40 protein assembly JASON DOUGLAS SALTER OYAGEN, INC. 2023-08-10
36 Antibody and Reagent Development Core DAISY W LEUNG WASHINGTON UNIVERSITY 2023-08-10
37 “Contributions of Ebola and Marburg virus VP30 and VP24 proteins to viral RNA synthesis, assembly and egress” CHRISTOPHER F BASLER WASHINGTON UNIVERSITY 2023-08-10
38 Development of Optofluidic Resonators for Filoviral Detection ABRAHAM JALEEL QAVI UNIVERSITY OF CALIFORNIA-IRVINE 2023-07-28
39 Optimizing Ridaifen-B analogs as potential therapeutics for Ebola viruses LIJUN RONG UNIVERSITY OF ILLINOIS AT CHICAGO 2023-07-25
40 NeuroEbola DANIEL DESIRE TSHALA-KATUMBAY OREGON HEALTH & SCIENCE UNIVERSITY 2023-07-21
41 “Development of Host- Oriented Therapeutics Targeting Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2),” RONALD N HARTY FOX CHASE CHEMICAL DIVERSITY CENTER, INC 2023-07-19
42 Pathogenesis of Uveitis in Ebola Virus Disease Survivors STEVEN YEH UNIVERSITY OF NEBRASKA MEDICAL CENTER 2023-07-18
43 Mechanisms of Ebola virus-mediated inflammatory activation linked to pathogenesis MICHAEL A BARRY MAYO CLINIC ROCHESTER 2023-07-11
44 Defining the protective or pathologic role of antibodies in Post-Ebola Syndrome JALENE VELAZQUEZ WASHINGTON STATE UNIVERSITY 2023-07-06
45 Specific and Broadly Active Monoclonal Antibody Therapeutics Against The Filoviruses ERICA OLLMANN SAPHIRE LA JOLLA INSTITUTE FOR IMMUNOLOGY 2023-06-28
46 Consortium for Immunotherapeutics against Emerging Viral Threats ERICA OLLMANN SAPHIRE LA JOLLA INSTITUTE FOR IMMUNOLOGY 2023-06-28
47 Cryo-EM of Helical Protein and Nucleoprotein Polymers at Near Atomic Resolution EDWARD H. EGELMAN UNIVERSITY OF VIRGINIA 2023-06-23
48 Cryo-EM of Helical Protein and Nucleoprotein Polymers at Near Atomic Resolution EDWARD H. EGELMAN UNIVERSITY OF VIRGINIA 2023-06-22
49 Dissecting the mechanisms of intestinal epithelial injury by Ebola virus using iPSC-derived intestinal organoids GUSTAVO MOSTOSLAVSKY BOSTON MEDICAL CENTER 2023-06-15
50 West African Center for Emerging Infectious Diseases SCOTT C WEAVER UNIVERSITY OF TEXAS MED BR GALVESTON 2023-06-12
51 Real-time tracking of virus evolution for vaccine strain selection and epidemiological investigation TREVOR BC BEDFORD FRED HUTCHINSON CANCER CENTER 2023-06-07
52 The Protective and Pathologic Features of the EVD Survivor Immune System WILLIAM FISCHER UNIV OF NORTH CAROLINA CHAPEL HILL 2023-05-09
53 Partnership for Research in Emerginig Viral Infections-Sierra Leone (PREVSL) D. TROY MOON TULANE UNIVERSITY OF LOUISIANA 2023-04-26
54 Training in Clinical and Epidemiological Research for Liberia (TRACER) JEFFREY N MARTIN UNIVERSITY OF CALIFORNIA, SAN FRANCISCO 2023-04-25
55 Rationally Designed Pan-Ebolavirus Vaccine M JAVAD AMAN ABVACC, INC. 2023-04-20
56 Role of the Glycocalyx and Spike-Like Proteins in Virus-Cell Adhesion XIAOHUI ZHANG; ANAND JAGOTA; LEHIGH UNIVERSITY 2023-04-15
57 Novel VP30-host Interactions that Negatively Regulate Ebola Virus Infection GAYA K. AMARASINGHE WASHINGTON UNIVERSITY 2023-03-27
58 Tolerance and resistance responses of African bats to viral antigens: Immunological tradeoffs in zoonotic reservoir hosts. DEEANN REEDER BUCKNELL UNIVERSITY 2023-03-23
59 Core A: Administrative Core ALEXANDER BUKREYEV UNIVERSITY OF TEXAS MED BR GALVESTON 2023-03-20
60 Molecular Mechanisms of the Dysregulated Immune Response to Ebola Virus ALEXANDER BUKREYEV UNIVERSITY OF TEXAS MED BR GALVESTON 2023-03-20
61 Research Project 3: Role of Posttranslational Protein Modifications in the Pathogenesis of Ebola Virus Disease RICARDO RAJSBAUM UNIVERSITY OF TEXAS MED BR GALVESTON 2023-03-20
62 Research Project 2: Role of Posttranscriptional Regulatory Networks in the Pathogenesis of Ebola Virus Disease MARIANO A. GARCIA-BLANCO UNIVERSITY OF TEXAS MED BR GALVESTON 2023-03-20
63 Research Project 1: Role of Epigenetic and Transcriptional Mechanisms in the Pathogenesis of Ebola Virus Disease ALEXANDER BUKREYEV UNIVERSITY OF TEXAS MED BR GALVESTON 2023-03-20
64 Novel VP30-host Interactions that Negatively Regulate Ebola Virus Infection GAYA K. AMARASINGHE WASHINGTON UNIVERSITY 2023-02-22
65 Preclinical development of a vaccine for Nipah virus THOMAS WILLIAM GEISBERT UNIVERSITY OF TEXAS MED BR GALVESTON 2023-02-07
66 Mali-Guinea Emerging Infectious Disease Research Training Program (Mali-Guinea EID-RTP) SEYDOU DOUMBIA UNIV OF SCIENCES, TECH & TECH OF BAMAKO 2023-02-07
67 Project 1 ROBERT F GARRY SCRIPPS RESEARCH INSTITUTE, THE 2023-01-04
68 Center for Viral Systems Biology (CViSB) KRISTIAN GRAUGAARD ANDERSEN SCRIPPS RESEARCH INSTITUTE, THE 2023-01-04
69 Project 2 KRISTIAN GRAUGAARD ANDERSEN SCRIPPS RESEARCH INSTITUTE, THE 2023-01-04
70 Merging machine learning and mechanistic models to improve prediction and inference in emerging epidemics JUSTIN LESSLER UNIV OF NORTH CAROLINA CHAPEL HILL 2022-12-28
71 Insight into the Ebola virus glycoprotein fusion mechanism gleaned from the 2013-2016 epidemic GP-A82V variant JEREMY LUBAN UNIV OF MASSACHUSETTS MED SCH WORCESTER 2022-12-01
72 Determining Tropism and Mechanisms of Ebola Virus Entry in Placental Tissues HANORA ANNE MARIE VAN ERT UNIVERSITY OF IOWA 2022-11-07
73 Functional genomic characterization of diverse bat innate immune mechanisms ANNA BRUCHEZ CASE WESTERN RESERVE UNIVERSITY 2022-11-07
74 Merging machine learning and mechanistic models to improve prediction and inference in emerging epidemics JUSTIN LESSLER UNIV OF NORTH CAROLINA CHAPEL HILL 2022-09-23
75 A Biomedical Mass Spectrometry Resource: Ongoing Driving Biomedical Projects MICHAEL L GROSS WASHINGTON UNIVERSITY 2022-09-22
76 Optimizing Ridaifen-B analogs as potential therapeutics for Ebola viruses LIJUN RONG UNIVERSITY OF ILLINOIS AT CHICAGO 2022-09-20
77 Genomic Characterization and Surveillance of Microbial Threats in West Africa CHRISTIAN T. HAPPI REDEEMER’S UNIVERSITY 2022-09-16
78 “Ebola modeling: behavior, asymptomatic infection, and contacts” TRAVIS CHRISTIAN PORCO UNIVERSITY OF CALIFORNIA, SAN FRANCISCO 2022-09-14
79 A modular platform for infectious disease surveillance at point-of-need. JAY KENNETH FISHER REDBUD LABS, INC. 2022-09-04
80 Elucidating mechanisms of interferon gamma that protect against Ebola virus infection WENDY JEAN MAURY UNIVERSITY OF IOWA 2022-09-02
81 “SBIR, Phase I (R43): Ultrasensitive Lateral Flow Assays Enabled by Fluorescent Nanodiamond Labels” OLGA A SHENDEROVA ADAMAS NANOTECHNOLOGIES, INC. 2022-09-01
82 Real-time tracking of virus evolution for vaccine strain selection and epidemiological investigation TREVOR BC BEDFORD FRED HUTCHINSON CANCER CENTER 2022-08-22
83 “Development of Host- Oriented Therapeutics Targeting Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2),” RONALD N HARTY FOX CHASE CHEMICAL DIVERSITY CENTER, INC 2022-08-22
84 Understanding the epidemiology and natural history of unrecognized Ebola virus infection JOHN DANIEL KELLY UNIVERSITY OF CALIFORNIA, SAN FRANCISCO 2022-08-18
85 A Fully Integrated Point-of-Care Test for Ebola ASHUTOSH CHILKOTI DUKE UNIVERSITY 2022-08-18
86 Hybrid Kinetic Monte Carlo Methods with Applications in Biofabrication and Epidemics YI SUN; UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA 2022-08-15
87 Mechanisms of Ebola virus-mediated inflammatory activation linked to pathogenesis MICHAEL A BARRY MAYO CLINIC ROCHESTER 2022-07-29
88 Antiviral Lead Identification to Treat Filovirus Infections VINCENT JO DAVISSON PURDUE UNIVERSITY 2022-07-28
89 NeuroEbola DANIEL DESIRE TSHALA-KATUMBAY OREGON HEALTH & SCIENCE UNIVERSITY 2022-07-28
90 Learning from the Ebola success: Can a mAb also save lives after yellow fever infection? DAVID I WATKINS MABLOC, LLC 2022-07-21
91 Development of Optofluidic Resonators for Filoviral Detection ABRAHAM JALEEL QAVI WASHINGTON UNIVERSITY 2022-07-19
92 Pathogenesis of Uveitis in Ebola Virus Disease Survivors STEVEN YEH UNIVERSITY OF NEBRASKA MEDICAL CENTER 2022-07-18
93 Design and Analysis of Vaccine Trials for Emerging Infectious Disease Threats NATALIE EXNER DEAN EMORY UNIVERSITY 2022-07-13
94 Dissecting the mechanisms of intestinal epithelial injury by Ebola virus using iPSC-derived intestinal organoids GUSTAVO MOSTOSLAVSKY BOSTON MEDICAL CENTER 2022-07-05
95 “Long term stress and impairment in children and youth after an acute infectious disease outbreak: A longitudinal study of the social, familial and individual effects of Ebola viral disease (EVD)” THOMAS M. CREA BOSTON COLLEGE 2022-06-15
96 Development of Antivirals against Filovirus Replication RALPH S BARIC UNIV OF NORTH CAROLINA CHAPEL HILL 2022-05-16
97 Project 1: Small Molecule Entry Inhibitors of Pandemic Viruses MING LUO UNIVERSITY OF MINNESOTA 2022-05-16
98 Cryo-EM of Helical Protein and Nucleoprotein Polymers at Near Atomic Resolution EDWARD H. EGELMAN UNIVERSITY OF VIRGINIA 2022-05-06
99 Consortium for Immunotherapeutics against Emerging Viral Threats ERICA OLLMANN SAPHIRE LA JOLLA INSTITUTE FOR IMMUNOLOGY 2022-05-04
100 Specific and Broadly Active Monoclonal Antibody Therapeutics Against The Filoviruses ERICA OLLMANN SAPHIRE LA JOLLA INSTITUTE FOR IMMUNOLOGY 2022-05-04
101 Training in Clinical and Epidemiological Research for Liberia (TRACER) JEFFREY N MARTIN UNIVERSITY OF CALIFORNIA, SAN FRANCISCO 2022-04-27
102 Regulation of Ebola virus replication by the host ubiquitin system RICARDO RAJSBAUM UNIVERSITY OF TEXAS MED BR GALVESTON 2022-04-25
103 Partnership for Research in Emerging Viral Infections-Sierra Leone (PREVSL) D. TROY MOON VANDERBILT UNIVERSITY MEDICAL CENTER 2022-04-25
104 Mali-Guinea Emerging Infectious Disease Research Training Program (Mali-Guinea EID-RTP) SEYDOU DOUMBIA UNIV OF SCIENCES, TECH & TECH OF BAMAKO 2022-04-18
105 Scalable Inference in Statistical Models of Viral Evolution and Human Health GABRIEL WILLIAM HASSLER UNIVERSITY OF CALIFORNIA LOS ANGELES 2022-04-07
106 Molecular Mechanisms of the Dysregulated Immune Response to Ebola Virus ALEXANDER BUKREYEV UNIVERSITY OF TEXAS MED BR GALVESTON 2022-04-05
107 Research Project 1: Role of Epigenetic and Transcriptional Mechanisms in the Pathogenesis of Ebola Virus Disease ALEXANDER BUKREYEV UNIVERSITY OF TEXAS MED BR GALVESTON 2022-04-05
108 Core A: Administrative Core ALEXANDER BUKREYEV UNIVERSITY OF TEXAS MED BR GALVESTON 2022-04-05
109 Research Project 3: Role of Posttranslational Protein Modifications in the Pathogenesis of Ebola Virus Disease RICARDO RAJSBAUM UNIVERSITY OF TEXAS MED BR GALVESTON 2022-04-05
110 Research Project 2: Role of Posttranscriptional Regulatory Networks in the Pathogenesis of Ebola Virus Disease MARIANO A. GARCIA-BLANCO UNIVERSITY OF TEXAS MED BR GALVESTON 2022-04-05
111 Intrinsically-enhanced Ebola and Marburg virus like particles for increased potency and immune memory JOANN M TUFARIELLO ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI 2022-03-30
112 Ebola virus infection of the female reproductive system ALEXANDER NICLAS FREIBERG UNIVERSITY OF TEXAS MED BR GALVESTON 2022-03-18
113 Spillover of Ebola and other filoviruses at ecological boundaries PATRICK STEPHENS OKLAHOMA STATE UNIVERSITY STILLWATER 2022-03-03
114 Consortium for Viral Systems Biology Technology Core BRYAN BRINEY SCRIPPS RESEARCH INSTITUTE 2022-02-25
115 Consortium for Viral Systems Biology (CViSB) KRISTIAN GRAUGAARD ANDERSEN SCRIPPS RESEARCH INSTITUTE 2022-02-25
116 Systems biology of Ebola virus and Lassa virus determinants of infection outcome KRISTIAN GRAUGAARD ANDERSEN SCRIPPS RESEARCH INSTITUTE 2022-02-25
117 Systems-level identification of host determinants of patient outcomes in Lassa fever and Ebola ROBERT F GARRY SCRIPPS RESEARCH INSTITUTE 2022-02-25
118 Novel VP30-host Interactions that Negatively Regulate Ebola Virus Infection GAYA K. AMARASINGHE WASHINGTON UNIVERSITY 2022-02-18
119 Tolerance and resistance responses of African bats to viral antigens: Immunological tradeoffs in zoonotic reservoir hosts. DEEANN REEDER BUCKNELL UNIVERSITY 2022-02-14
120 Tunneling nanotubes as an alternate route of Ebola virus dissemination OLENA SHTANKO TEXAS BIOMEDICAL RESEARCH INSTITUTE 2022-02-02
121 Small Molecule Inhibitors of Ebola Virus Polymerase Function CHRISTOPHER F BASLER ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI 2021-12-23
122 Molecular Mechanisms of Viral Entry by Membrane Fusion LUKAS K TAMM UNIVERSITY OF VIRGINIA 2021-12-17
123 Insight into the Ebola virus glycoprotein fusion mechanism gleaned from the 2013-2016 epidemic GP-A82V variant JEREMY LUBAN UNIV OF MASSACHUSETTS MED SCH WORCESTER 2021-12-15
124 A Novel Broad-spectrum Antiviral Agent JOANA M MURAD CELDARA MEDICAL, LLC 2021-12-09
125 Evaluation of ARN-75039 for dual efficacy against both parenteral and aerosolized Lassa virus infection in a guinea pig model. GREG HENKEL ARISAN THERAPEUTICS, INC. 2021-09-25
126 GH19-003, Epidemiology and Immunity to Ebola Virus and Other Emerging Viral Infections in Liberia AXEL T LEHRER UNIVERSITY OF HAWAII AT MANOA 2021-09-21
127 Pathogenesis of Uveitis in Ebola Virus Disease Survivors STEVEN YEH UNIVERSITY OF NEBRASKA MEDICAL CENTER 2021-09-17
128 NeuroEbola NGOYI MUMBA OREGON HEALTH & SCIENCE UNIVERSITY 2021-09-09
129 Consortium for Viral Systems Biology (CViSB) KRISTIAN GRAUGAARD ANDERSEN SCRIPPS RESEARCH INSTITUTE 2021-09-07
130 West African Center for Emerging Infectious Diseases SCOTT C WEAVER UNIVERSITY OF TEXAS MED BR GALVESTON 2021-09-02
131 Project 1 Viral Genomics: surveillance, epidemiology, host response, and viral immunogenicity PARDIS CHRISTINE SABETI BROAD INSTITUTE, INC. 2021-08-30
132 Project 1 Viral Genomics: surveillance, epidemiology, host response, and viral immunogenicity PARDIS CHRISTINE SABETI BROAD INSTITUTE, INC. 2021-08-27
133 Ebola modeling: behavior, asymptomatic infection, and contacts TRAVIS CHRISTIAN PORCO UNIVERSITY OF CALIFORNIA, SAN FRANCISCO 2021-08-27
134 Project 1 Viral Genomics: surveillance, epidemiology, host response, and viral immunogenicity PARDIS CHRISTINE SABETI BROAD INSTITUTE, INC. 2021-08-26
135 Partnership for Research in Emerging Viral Infections-Sierra Leone (PREVSL) DONALD SAMUEL GRANT VANDERBILT UNIVERSITY MEDICAL CENTER 2021-08-24
136 Genomic Characterization and Surveillance of Microbial Threats in West Africa CHRISTIAN T. HAPPI REDEEMER’S UNIVERSITY 2021-08-24
137 Prospectively characterizing the functional and antigenic effects of mutations to viral entry proteins JESSE D BLOOM FRED HUTCHINSON CANCER RESEARCH CENTER 2021-08-19
138 Design and Analysis of Vaccine Trials for Emerging Infectious Disease Threats NATALIE EXNER DEAN EMORY UNIVERSITY 2021-08-12
139 A Fully Integrated Point-of-Care Test for Ebola ASHUTOSH CHILKOTI DUKE UNIVERSITY 2021-08-11
140 Learning from the Ebola success: Can a mAb also save lives after yellow fever infection? JONAH B. SACHA MABLOC, LLC 2021-08-06
141 Mechanisms of Ebola virus-mediated inflammatory activation linked to pathogenesis MICHAEL A BARRY MAYO CLINIC ROCHESTER 2021-08-05
142 Field Diagnostics for Pathogen Identification and Surveillance DONALD SAMUEL GRANT REDEEMER’S UNIVERSITY 2021-08-04
143 Use Clinical, Genomic, and Immunological Data for Studying Viral and Host Biology PETER OKOKHORE REDEEMER’S UNIVERSITY 2021-08-04
144 Genomic Characterization and Surveillance of Microbial Threats in West Africa CHRISTIAN T. HAPPI REDEEMER’S UNIVERSITY 2021-08-04
145 Understanding the epidemiology and natural history of unrecognized Ebola virus infection JOHN DANIEL KELLY UNIVERSITY OF CALIFORNIA, SAN FRANCISCO 2021-07-23
146 Targeted therapeutics against filoviral hemorrhagic fever LIAM KING UNIVERSITY OF CALIFORNIA, SAN DIEGO 2021-07-16
147 Antiviral Lead Identification to Treat Filovirus Infections ROBERT A DAVEY PURDUE UNIVERSITY 2021-07-16
148 A modular platform for infectious disease surveillance at point-of-need. JAY KENNETH FISHER REDBUD LABS, INC. 2021-07-14
149 4-(Aminomethyl) benzamides as novel anti-Ebola agents LIJUN RONG CHICAGO BIOSOLUTIONS, INC. 2021-07-14
150 Structure-based design of novel Lassa virus glycoproteins for vaccine development ROBERT F GARRY TULANE UNIVERSITY OF LOUISIANA 2021-07-06
151 Stimulating innate immunity to protect against Ebola virus infection GEORGE NORBERT COX BOLDER BIOTECHNOLOGY, INC. 2021-07-02
152 Structure-based design of novel Lassa virus glycoproteins for vaccine development ROBERT F GARRY TULANE UNIVERSITY OF LOUISIANA 2021-06-30
153 A Biomedical Mass Spectrometry Resource: Ongoing Driving Biomedical Projects MICHAEL L GROSS WASHINGTON UNIVERSITY 2021-06-30
154 A ‘Trojan Horse’ bispecific antibody strategy for broad filovirus therapeutics KARTIK CHANDRAN ALBERT EINSTEIN COLLEGE OF MEDICINE 2021-06-29
155 Discovery of antiviral inhibitors of Ebola virus replication GLEN ANDREW COBURN VENATORX PHARMACEUTICALS, INC. 2021-06-24
156 Long term stress and impairment in children and youth after an acute infectious disease outbreak: A longitudinal study of the social, familial and individual effects of Ebola viral disease (EVD) THOMAS M. CREA BOSTON COLLEGE 2021-06-18
157 Targeted therapeutics against filoviral hemorrhagic fever LIAM KING UNIVERSITY OF CALIFORNIA, SAN DIEGO 2021-06-16
158 West African Center for Emerging Infectious Diseases SCOTT C WEAVER UNIVERSITY OF TEXAS MED BR GALVESTON 2021-06-11
159 Whispering Gallery Mode Devices for the Rapid Detection of Pan-Filoviruses GAYA K. AMARASINGHE INTEGRATED BIOTHERAPEUTICS, INC. 2021-06-10
160 Hazardous Materials Worker Health and Safety Training- HDPTP MITCHEL A ROSEN RBHS-SCHOOL OF PUBLIC HEALTH 2021-06-08
161 Intrinsically-enhanced Ebola and Marburg virus like particles for increased potency and immune memory JOANN M TUFARIELLO GEORGIA STATE UNIVERSITY 2021-06-02
162 Rationally Designed Pan-Ebolavirus Vaccine M JAVAD AMAN INTEGRATED BIOTHERAPEUTICS, INC. 2021-05-26
163 Condensation and CANARY: A Multiplex Bioaerosol Threat Detector TIMOTHY GORDON AEROSOL DEVICES INC. 2021-05-12
164 Regulation of Ebola virus replication by the host ubiquitin system RICARDO RAJSBAUM UNIVERSITY OF TEXAS MED BR GALVESTON 2021-05-12
165 Spillover of Ebola and other filoviruses at ecological boundaries PATRICK STEPHENS UNIVERSITY OF GEORGIA 2021-05-12
166 Consortium for Immunotherapeutics against Emerging Viral Threats ERICA OLLMANN SAPHIRE LA JOLLA INSTITUTE FOR IMMUNOLOGY 2021-05-06
167 Specific and Broadly Active Monoclonal Antibody Therapeutics Against The Filoviruses ERICA OLLMANN SAPHIRE LA JOLLA INSTITUTE FOR IMMUNOLOGY 2021-05-06
168 Cryo-EM of Helical Protein and Nucleoprotein Polymers at Near Atomic Resolution EDWARD H. EGELMAN UNIVERSITY OF VIRGINIA 2021-04-29
169 Regulation of Ebola virus replication by the host ubiquitin system RICARDO RAJSBAUM UNIVERSITY OF TEXAS MED BR GALVESTON 2021-04-27
170 Real-time tracking of virus evolution for vaccine strain selection and epidemiological investigation TREVOR BC BEDFORD FRED HUTCHINSON CANCER RESEARCH CENTER 2021-04-23
171 Ebola virus infection of the female reproductive system ALEXANDER NICLAS FREIBERG UNIVERSITY OF TEXAS MED BR GALVESTON 2021-04-21
172 West African Emerging Infectious Disease Research Center (WA-EIDRC) KRISTIAN GRAUGAARD ANDERSEN SCRIPPS RESEARCH INSTITUTE 2021-04-16
173 Research Project 2: Role of Posttranscriptional Regulatory Networks in the Pathogenesis of Ebola Virus Disease MARIANO A. GARCIA-BLANCO UNIVERSITY OF TEXAS MED BR GALVESTON 2021-04-16
174 Core A: Administrative Core ALEXANDER BUKREYEV UNIVERSITY OF TEXAS MED BR GALVESTON 2021-04-16
175 Molecular Mechanisms of the Dysregulated Immune Response to Ebola Virus ALEXANDER BUKREYEV UNIVERSITY OF TEXAS MED BR GALVESTON 2021-04-16
176 Research Project 1: Role of Epigenetic and Transcriptional Mechanisms in the Pathogenesis of Ebola Virus Disease ALEXANDER BUKREYEV UNIVERSITY OF TEXAS MED BR GALVESTON 2021-04-16
177 Research Project 3: Role of Posttranslational Protein Modifications in the Pathogenesis of Ebola Virus Disease RICARDO RAJSBAUM UNIVERSITY OF TEXAS MED BR GALVESTON 2021-04-16
178 Scalable Inference in Statistical Models of Viral Evolution and Human Health GABRIEL WILLIAM HASSLER UNIVERSITY OF CALIFORNIA LOS ANGELES 2021-04-12
179 Structure-based design of novel Lassa virus glycoproteins for vaccine development ROBERT F GARRY TULANE UNIVERSITY OF LOUISIANA 2021-04-12
180 A Transgenic Mouse Model to Study Ebolaviruses and other Filoviruses YOSHIHIRO KAWAOKA UNIVERSITY OF WISCONSIN-MADISON 2021-04-06
181 Project 1 Viral Genomics: surveillance, epidemiology, host response, and viral immunogenicity PARDIS CHRISTINE SABETI BROAD INSTITUTE, INC. 2021-04-01
182 Reproductive health sequelae in women who survived Ebola Virus Disease in Sierra Leone and Liberia CHRISTINE LEIGH GODWIN FAMILY HEALTH INTERNATIONAL 2021-03-29
183 Engineering pathogen triggered biomineralization to enable a new generation of point-of-care tests ANDREW HAYHURST TEXAS BIOMEDICAL RESEARCH INSTITUTE 2021-03-24
184 Consortium for Viral Systems Biology (CViSB) KRISTIAN GRAUGAARD ANDERSEN SCRIPPS RESEARCH INSTITUTE 2021-03-24
185 Training in Clinical and Epidemiological Research for Liberia (TRACER) JEFFREY N MARTIN UNIVERSITY OF CALIFORNIA, SAN FRANCISCO 2021-03-20
186 Partnership for Research in Emerging Viral Infections-Sierra Leone (PREVSL) DONALD SAMUEL GRANT VANDERBILT UNIVERSITY MEDICAL CENTER 2021-03-19
187 Consortium for Viral Systems Biology (CViSB) KRISTIAN GRAUGAARD ANDERSEN SCRIPPS RESEARCH INSTITUTE 2021-03-18
188 Systems biology of Ebola virus and Lassa virus determinants of infection outcome KRISTIAN GRAUGAARD ANDERSEN SCRIPPS RESEARCH INSTITUTE 2021-03-18
189 Systems-level identification of host determinants of patient outcomes in Lassa fever and Ebola ROBERT F GARRY SCRIPPS RESEARCH INSTITUTE 2021-03-18
190 Consortium for Viral Systems Biology (CViSB) KRISTIAN GRAUGAARD ANDERSEN SCRIPPS RESEARCH INSTITUTE 2021-03-18
191 Consortium for Viral Systems Biology Technology Core BRYAN BRINEY SCRIPPS RESEARCH INSTITUTE 2021-03-18
192 Preclinical development of a vaccine for Nipah virus THOMAS WILLIAM GEISBERT UNIVERSITY OF TEXAS MED BR GALVESTON 2021-03-10
193 STTR Phase I: A system for collection, transportation and accurate analysis of RNA virus specimens AVINOAM DUKLER; KEPLER DIAGNOSTICS INC. 2021-02-01
194 Collaborative Research: National Symposium on PRedicting Emergence of Virulent Entities by Novel Technologies (PREVENT) PAUL TORRENS; NEW YORK UNIVERSITY 2021-02-01
195 RAPID: Curtailing Nosocomial Amplification of COVID-19 KASEY JONES; SARAH RHEA; ASSEFAW GEBREMEDHIN; ERIC LOFGREN; WASHINGTON STATE UNIVERSITY 2021-02-01
196 Insight into the Ebola virus glycoprotein fusion mechanism gleaned from the 2013-2016 epidemic GP-A82V variant JEREMY LUBAN UNIV OF MASSACHUSETTS MED SCH WORCESTER 2021-01-29
197 Tunneling nanotubes as an alternate route of Ebola virus dissemination OLENA SHTANKO TEXAS BIOMEDICAL RESEARCH INSTITUTE 2021-01-27
198 Insight into the Ebola virus glycoprotein fusion mechanism gleaned from the 2013-2016 epidemic GP-A82V variant JEREMY LUBAN UNIV OF MASSACHUSETTS MED SCH WORCESTER 2021-01-27
199 Merging machine learning and mechanistic models to improve prediction and inference in emerging epidemics JESSIE EDWARDS JOHNS HOPKINS UNIVERSITY 2021-01-26
200 Small Molecule Inhibitors of Ebola Virus Polymerase Function CHRISTOPHER F BASLER GEORGIA STATE UNIVERSITY 2021-01-22
201 A Novel Broad-spectrum Antiviral Agent JASON W. BOTTEN CELDARA MEDICAL, LLC 2020-12-31
202 Structure-Based Design of Peptide Entry Inhibitors against Ebola Virus Infection SHI-HUA XIANG UNIVERSITY OF NEBRASKA LINCOLN 2020-12-30
203 Consortium for Viral Systems Biology Data Management and Bioinformatics Core ANDREW I SU SCRIPPS RESEARCH INSTITUTE 2020-12-11
204 Consortium for Viral Systems Biology Technology Core BRYAN BRINEY SCRIPPS RESEARCH INSTITUTE 2020-12-11
205 Consortium for Viral Systems Biology (CViSB) KRISTIAN GRAUGAARD ANDERSEN SCRIPPS RESEARCH INSTITUTE 2020-12-11
206 Systems-level identification of host determinants of patient outcomes in Lassa fever and Ebola ROBERT F GARRY SCRIPPS RESEARCH INSTITUTE 2020-12-11
207 Systems biology of Ebola virus and Lassa virus determinants of infection outcome KRISTIAN GRAUGAARD ANDERSEN SCRIPPS RESEARCH INSTITUTE 2020-12-11
208 Molecular Mechanisms of Viral Entry by Membrane Fusion LUKAS K TAMM UNIVERSITY OF VIRGINIA 2020-12-07
209 Host-virus interactions in the control of filovirus entry KARTIK CHANDRAN ALBERT EINSTEIN COLLEGE OF MEDICINE 2020-11-25
210 The role of macrophage podosomes in Ebola virus pathogenesis OLENA SHTANKO TEXAS BIOMEDICAL RESEARCH INSTITUTE 2020-11-12
211 A Fully Integrated Point-of-Care Test for Ebola ASHUTOSH CHILKOTI DUKE UNIVERSITY 2020-09-23
212 EAGER: Integrating animal movement ecology and multi-level social networks to investigate zoonotic disease dynamics TERI ORR; KAREN MABRY; NEW MEXICO STATE UNIVERSITY 2020-09-15
213 Center for dynamic RNA epitranscriptomes – Covid 19 Supplement Version 2 CHUAN HE UNIVERSITY OF CHICAGO 2020-09-11
214 Network epidemiology and the quantification of behavioral interventions LAURENT H�BERT-DUFRESNE UNIVERSITY OF VERMONT & ST AGRIC COLLEGE 2020-09-08
215 Consortium for Viral Systems Biology (CViSB) KRISTIAN GRAUGAARD ANDERSEN SCRIPPS RESEARCH INSTITUTE 2020-09-03
216 Electrochromic + Anti-Fog + Prescription Lens Personal-Protective Equipment (PPE) Eyewear Based on Unique, Very Low Power, Conductive Coatings and Leveraging Unique, ANSI Z87.1-/Military-Qualified Ele PRASANNA CHANDRASEKHAR ASHWIN-USHAS CORPORATION 2020-09-01
217 Antibody therapeutics for human viral hemorrhagic fevers and prevention of late neurological syndromes JONATHAN ABRAHAM HARVARD MEDICAL SCHOOL 2020-08-25
218 Design and Analysis of Vaccine Trials for Emerging Infectious Disease Threats NATALIE EXNER DEAN UNIVERSITY OF FLORIDA 2020-08-24
219 Ebola modeling: behavior, asymptomatic infection, and contacts TRAVIS CHRISTIAN PORCO UNIVERSITY OF CALIFORNIA, SAN FRANCISCO 2020-08-20
220 The Impact of Ebola Infection on Demographic and Social Outcomes in Sierra Leone PHILIP ANTHONY ANGLEWICZ JOHNS HOPKINS UNIVERSITY 2020-08-20
221 Prospectively characterizing the functional and antigenic effects of mutations to viral entry proteins JESSE D BLOOM FRED HUTCHINSON CANCER RESEARCH CENTER 2020-08-13
222 GH19-003, Epidemiology and Immunity to Ebola Virus and Other Emerging Viral Infections in Liberia AXEL T LEHRER UNIVERSITY OF HAWAII AT MANOA 2020-08-13
223 A modular platform for infectious disease surveillance at point-of-need. JAY KENNETH FISHER REDBUD LABS, INC. 2020-08-07
224 Understanding the epidemiology and natural history of unrecognized Ebola virus infection JOHN DANIEL KELLY UNIVERSITY OF CALIFORNIA, SAN FRANCISCO 2020-07-28
225 Pathogenesis of Uveitis in Ebola Virus Disease Survivors STEVEN YEH EMORY UNIVERSITY 2020-07-27
226 Operational Research for Disease Surveillance Enhancement in Uganda (ORDiSE-U) ANDREW DDUNGU KAMBUGU INFECTIOUS DISEASES INSTITUTE 2020-07-23
227 Hazardous Materials Worker Health and Safety Training- HDPTP MITCHEL A ROSEN RBHS-SCHOOL OF PUBLIC HEALTH 2020-07-21
228 Antiviral Lead Identification to Treat Filovirus Infections ROBERT A DAVEY PURDUE UNIVERSITY 2020-07-16
229 Discovery of antiviral inhibitors of Ebola virus replication GLEN ANDREW COBURN VENATORX PHARMACEUTICALS, INC. 2020-07-14
230 Mechanisms of Ebola virus-mediated inflammatory activation linked to pathogenesis HIDEKI EBIHARA MAYO CLINIC ROCHESTER 2020-07-14
231 Modeling Filovirus Infection of and Trafficking through Skin WENDY JEAN MAURY UNIVERSITY OF IOWA 2020-07-08
232 Whispering Gallery Mode Devices for the Rapid Detection of Pan-Filoviruses GAYA K. AMARASINGHE INTEGRATED BIOTHERAPEUTICS, INC. 2020-07-06
233 Learning from the Ebola success: Can a mAb also save lives after yellow fever infection? JONAH B. SACHA MABLOC, LLC 2020-07-02
234 4-(Aminomethyl) benzamides as novel anti-Ebola agents LIJUN RONG CHICAGO BIOSOLUTIONS, INC. 2020-07-01
235 Protein Production and Protein Interaction Core DAISY LEUNG WASHINGTON UNIVERSITY 2020-07-01
236 Defining the Role of Host Factors in Ebola Virus RNA Synthesis DOUGLAS J. LACOUNT WASHINGTON UNIVERSITY 2020-07-01
237 Structural Mechanisms of Ebola Virus RNA Synthesis GAYA K. AMARASINGHE WASHINGTON UNIVERSITY 2020-07-01
238 Use Clinical, Genomic, and Immunological Data for Studying Viral and Host Biology PETER OKOKHORE REDEEMER’S UNIVERSITY 2020-07-01
239 Genomic Characterization and Surveillance of Microbial Threats in West Africa CHRISTIAN T. HAPPI REDEEMER’S UNIVERSITY 2020-07-01
240 Field Diagnostics for Pathogen Identification and Surveillance DONALD SAMUEL GRANT REDEEMER’S UNIVERSITY 2020-07-01
241 Structural and Functional Characterization of the Ebola Virus Replication Complex GAYA K. AMARASINGHE WASHINGTON UNIVERSITY 2020-07-01
242 Long term stress and impairment in children and youth after an acute infectious disease outbreak: A longitudinal study of the social, familial and individual effects of Ebola viral disease (EVD) THOMAS M. CREA BOSTON COLLEGE 2020-06-30
243 RAPID/Collaborative Research: Agency COVID-19 Risk Communication on Social Media: Characterizing Drivers of Message Retransmission and Engagement JEANNETTE SUTTON; SUNY AT ALBANY 2020-06-30
244 Structure-based design of novel Lassa virus glycoproteins for vaccine development ROBERT F GARRY TULANE UNIVERSITY OF LOUISIANA 2020-06-25
245 Mechanisms of Membrane Fusion WILLIAM TOBEY WICKNER DARTMOUTH COLLEGE 2020-06-24
246 Project 1 Viral Genomics: surveillance, epidemiology, host response, and viral immunogenicity PARDIS CHRISTINE SABETI BROAD INSTITUTE, INC. 2020-06-18
247 Spillover of Ebola and other filoviruses at ecological boundaries PATRICK STEPHENS UNIVERSITY OF GEORGIA 2020-06-17
248 Simulation Education for Ebola Healthcare Team Competency JOSEPH G REVES SIMTUNES, INC. 2020-06-13
249 A ‘Trojan Horse’ bispecific antibody strategy for broad filovirus therapeutics KARTIK CHANDRAN ALBERT EINSTEIN COLLEGE OF MEDICINE 2020-06-12
250 Hazardous Waste Worker Training Program (HWWTP) JANELLE RIOS UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON 2020-06-10
251 Targeted therapeutics against filoviral hemorrhagic fever LIAM KING LA JOLLA INSTITUTE FOR IMMUNOLOGY 2020-06-10
252 West African Center for Emerging Infectious Diseases SCOTT C WEAVER UNIVERSITY OF TEXAS MED BR GALVESTON 2020-06-09
253 Deep characterization of the biogenesis and function of Ebola virus microRNAs DANIEL CIFUENTES BOSTON UNIVERSITY MEDICAL CAMPUS 2020-06-03
254 Intrinsically-enhanced Ebola and Marburg virus like particles for increased potency and immune memory JOANN M TUFARIELLO GEORGIA STATE UNIVERSITY 2020-05-28
255 A Transgenic Mouse Model to Study Ebolaviruses and other Filoviruses YOSHIHIRO KAWAOKA UNIVERSITY OF WISCONSIN-MADISON 2020-05-22
256 West African Emerging Infectious Disease Research Center (WA-EIDRC) KRISTIAN GRAUGAARD ANDERSEN SCRIPPS RESEARCH INSTITUTE 2020-05-21
257 Consortium for Viral Systems Biology (CViSB) KRISTIAN GRAUGAARD ANDERSEN SCRIPPS RESEARCH INSTITUTE 2020-05-15
258 Rationally Designed Pan-Ebolavirus Vaccine M JAVAD AMAN INTEGRATED BIOTHERAPEUTICS, INC. 2020-05-13
259 Project 1 Viral Genomics: surveillance, epidemiology, host response, and viral immunogenicity PARDIS CHRISTINE SABETI BROAD INSTITUTE, INC. 2020-05-12
260 Real-time tracking of virus evolution for vaccine strain selection and epidemiological investigation TREVOR BC BEDFORD FRED HUTCHINSON CANCER RESEARCH CENTER 2020-05-12
261 Specific and Broadly Active Monoclonal Antibody Therapeutics Against The Filoviruses ERICA OLLMANN SAPHIRE LA JOLLA INSTITUTE FOR IMMUNOLOGY 2020-05-04
262 Consortium for Immunotherapeutics against Emerging Viral Threats ERICA OLLMANN SAPHIRE LA JOLLA INSTITUTE FOR IMMUNOLOGY 2020-05-04
263 RAPID: Funerary Practices, Pandemic Confinement, and the Implications for COVID-19 Transmission JOEL KUIPERS; ROY RICHARD GRINKER; SARAH WAGNER; DEVIN PROCTOR; JORGE BENAVIDES-RAWSON; GEORGE WASHINGTON UNIVERSITY 2020-05-01
264 RAPID: Responding to a Global Pandemic–The Role of K-12 Science Teachers PATRICK SMITH; PEGGY TRYGSTAD; HORIZON RESEARCH INC 2020-05-01
265 Cryo-EM of Helical Protein and Nucleoprotein Polymers at Near Atomic Resolution EDWARD H. EGELMAN UNIVERSITY OF VIRGINIA 2020-04-30
266 Training in Clinical and Epidemiological Research for Liberia (TRACER) JEFFREY N MARTIN UNIVERSITY OF CALIFORNIA, SAN FRANCISCO 2020-04-27
267 Partnership for Research in Emerging Viral Infections-Sierra Leone (PREVSL) DONALD SAMUEL GRANT VANDERBILT UNIVERSITY MEDICAL CENTER 2020-04-23
268 Ebola modeling: behavior, asymptomatic infection, and contacts (2019-nCoV Admin Supplement) TRAVIS CHRISTIAN PORCO UNIVERSITY OF CALIFORNIA, SAN FRANCISCO 2020-04-10
269 Regulation of Ebola virus replication by the host ubiquitin system RICARDO RAJSBAUM UNIVERSITY OF TEXAS MED BR GALVESTON 2020-04-07
270 Predicted Role of Ebola VP40-Host Interactions in Ocular Pathology and Persistence RONALD N HARTY UNIVERSITY OF PENNSYLVANIA 2020-03-31
271 A Biomedical Mass Spectrometry Resource: Ongoing Driving Biomedical Projects MICHAEL L GROSS WASHINGTON UNIVERSITY 2020-03-31
272 Clinical Sequelae and Urogenital Viral Dynamics in Survivors of Ebola Virus Disease WILLIAM FISCHER UNIV OF NORTH CAROLINA CHAPEL HILL 2020-03-30
273 Reproductive health sequelae in women who survived Ebola Virus Disease in Sierra Leone and Liberia CHRISTINE LEIGH GODWIN FAMILY HEALTH INTERNATIONAL 2020-03-23
274 Engineering pathogen triggered biomineralization to enable a new generation of point-of-care tests ANDREW HAYHURST TEXAS BIOMEDICAL RESEARCH INSTITUTE 2020-03-17
275 CD40 regulation of acute virus infection WENDY JEAN MAURY UNIVERSITY OF IOWA 2020-03-11
276 Point-of-care antigen detection assay for early diagnosis of Ebola virus disease (EVD) DAVID P AUCOIN INBIOS INTERNATIONAL, INC. 2020-03-10
277 Administrative Core (Core A) THOMAS WILLIAM GEISBERT UNIVERSITY OF TEXAS MED BR GALVESTON 2020-03-05
278 Development of novel endosome-targeted Ebola virus entry inhibitors as antiviral agents MATTEO POROTTO COLUMBIA UNIVERSITY HEALTH SCIENCES 2020-02-26
279 Novel VP30-host Interactions that Negatively Regulate Ebola Virus Infection GAYA K. AMARASINGHE WASHINGTON UNIVERSITY 2020-02-19
280 Social Epidemiology of Ebola Virus Disease EUGENE THOMAS RICHARDSON HARVARD MEDICAL SCHOOL 2020-02-14
281 Transmission: Astonishing Tales of Human-Animal Diseases MARTIN M WEISS NEW YORK HALL OF SCIENCE 2020-02-10
282 Development of Small Molecule Therapeutics for Emerging Viral Agents GREG HENKEL ARISAN THERAPEUTICS, INC. 2020-02-06
283 Development of Small Molecule Therapeutics for Emerging Viral Agents KEN MCCORMACK ARISAN THERAPEUTICS, INC. 2020-02-03
284 Prevalence, Pathogenesis, and Persistence of Lassa Fever in West Africa WILLIAM FISCHER UNIV OF NORTH CAROLINA CHAPEL HILL 2020-01-31
285 Small Molecule Inhibitors of Ebola Virus Polymerase Function CHRISTOPHER F BASLER GEORGIA STATE UNIVERSITY 2020-01-24
286 Consortium for Viral Systems Biology (CViSB) KRISTIAN GRAUGAARD ANDERSEN SCRIPPS RESEARCH INSTITUTE 2020-01-23
287 Systems-level identification of host determinants of patient outcomes in Lassa fever and Ebola ROBERT F GARRY SCRIPPS RESEARCH INSTITUTE 2020-01-23
288 Systems biology of Ebola virus and Lassa virus determinants of infection outcome KRISTIAN GRAUGAARD ANDERSEN SCRIPPS RESEARCH INSTITUTE 2020-01-23
289 Consortium for Viral Systems Biology Data Management and Bioinformatics Core ANDREW I SU SCRIPPS RESEARCH INSTITUTE 2020-01-23
290 Consortium for Viral Systems Biology Technology Core BRYAN BRINEY SCRIPPS RESEARCH INSTITUTE 2020-01-23
291 Real-Time Unbiased Pathogen Detection in Febrile Illnesses by Nanopore Sequencing CHARLES YEN CHIU UNIVERSITY OF CALIFORNIA, SAN FRANCISCO 2020-01-23
292 Pan-Genomic Approaches for Comprehensive Blood Screening of Novel or Emerging Infectious Agents CHARLES YEN CHIU UNIVERSITY OF CALIFORNIA, SAN FRANCISCO 2020-01-04
293 Molecular Mechanisms of Viral Entry by Membrane Fusion LUKAS K TAMM UNIVERSITY OF VIRGINIA 2019-12-30
294 Insight into the Ebola virus glycoprotein fusion mechanism gleaned from the 2013-2016 epidemic GP-A82V variant JEREMY LUBAN UNIV OF MASSACHUSETTS MED SCH WORCESTER 2019-12-27
295 Function and assembly of the Ebola virus nucleocapsid ERICA OLLMANN SAPHIRE LA JOLLA INST FOR ALLERGY & IMMUNOLGY 2019-12-11
296 Cell-based assay directly monitoring viral polymerase activity for drug discovery. CAROLYN CARR LUCERNA, INC. 2019-12-05
297 Structural dynamics of single Ebolavirus GP molecules. JAMES B MUNRO UNIV OF MASSACHUSETTS MED SCH WORCESTER 2019-11-27